2 results
Approved WMOCompleted
To assess the treatment effect of BEZ235 relative to everolimus on progression free survival in patients with advanced pancreatic neuroendocrine tumors who have not been previously treated with an mTOR inhibitor.
Approved WMOCompleted
Efficacy of BEZ235 on objective response rate according to RECIST 1.1